Drugs / Flu-ID
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00554333 | Oct → Dec 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flu-ID | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00554333 ↗ |
| Modality | Vaccine | “Inactivated Split-Virion Influenza Vaccine for Intradermal Route” NCT00554333 ↗ |